Discontinuation Study of the Durability of Effect of Milnacipran for the Treatment of Fibromyalgia
Public ClinicalTrials.gov record NCT01014585. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Placebo-Controlled Discontinuation Study of the Durability of Effect of Milnacipran for the Treatment of Fibromyalgia in Patients Receiving Long-term Milnacipran Treatment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the durability of effect of milnacipran for the treatment of fibromyalgia in patients receiving long-term milnacipran treatment and to characterize the effects of milnacipran on multiple symptoms of fibromyalgia, as demonstrated by changes in symptoms following the discontinuation of milnacipran.
Study identification
- NCT ID
- NCT01014585
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 340 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2009 (Type not available)
- Primary completion
- May 2010 (Actual)
- Completion
- Not listed
- Last update posted
- Sep 7, 2011
Started 2009
United States locations
- U.S. sites
- 58
- U.S. states
- 26
- U.S. cities
- 54
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site 062 | Birmingham | Alabama | 35205 | — |
| Forest Investigative Site 065 | Birmingham | Alabama | 35209 | — |
| Forest Investigative Site 012 | Tucson | Arizona | 85704 | — |
| Forest Investigative Site 007 | Fresno | California | 93710 | — |
| Forest Investigative Site 032 | Pismo Beach | California | 93449 | — |
| Forest Investigative Site 025 | Sacramento | California | 95825 | — |
| Forest Investigative Site 019 | San Diego | California | 92108 | — |
| Forest Investigative Site 057 | Santa Ana | California | 92705 | — |
| Forest Investigative Site 039 | Vista | California | 92083 | — |
| Forest Investigative Site 050 | Cromwell | Connecticut | 06416 | — |
| Forest Investigative Site 049 | Danbury | Connecticut | 06810 | — |
| Forest Investigative Site 055 | Stamford | Connecticut | 06905 | — |
| Forest Investigative Site 011 | Delray Beach | Florida | 33484 | — |
| Forest Investigative Site 013 | Ocala | Florida | 34471 | — |
| Forest Investigative Site 016 | Orlando | Florida | 32806 | — |
| Forest Investigative Site 043 | Palm Harbor | Florida | 34684 | — |
| Forest Investigative Site 060 | Pembroke Pines | Florida | 33029 | — |
| Forest Investigative Site 066 | Atlanta | Georgia | 30319 | — |
| Forest Investigative Site 009 | Atlanta | Georgia | 30328 | — |
| Forest Investigative Site 026 | Honolulu | Hawaii | 96814 | — |
| Forest Investigative Site 056 | Libertyville | Illinois | 60048 | — |
| Forest Investigative Site 038 | Peoria | Illinois | 61614 | — |
| Forest Investigative Site 031 | Evansville | Indiana | 47713 | — |
| Forest Investigative Site 064 | Frederick | Maryland | 21702 | — |
| Forest Investigative Site 030 | Newton | Massachusetts | 02462 | — |
| Forest Investigative Site 048 | North Dartmouth | Massachusetts | 02747 | — |
| Forest Investigative Site 017 | Springfield | Massachusetts | 01103 | — |
| Forest Investigative Site 008 | Worcester | Massachusetts | 01610 | — |
| Forest Investigative Site 061 | Kalamazoo | Michigan | 49009 | — |
| Forest Investigative Site 020 | Jackson | Mississippi | 39202 | — |
| Forest Investigative Site 004 | St Louis | Missouri | 63141 | — |
| Forest Investigative Site 033 | Cherry Hill | New Jersey | 08002 | — |
| Forest Investigative Site 040 | Albuquerque | New Mexico | 87108 | — |
| Forest Investigative Site 035 | Great Neck | New York | 11021 | — |
| Forest Investigative Site 014 | Rochester | New York | 14618 | — |
| Forest Investigative Site 027 | Syracuse | New York | 13210 | — |
| Forest Investigative Site 054 | Charlotte | North Carolina | 28209 | — |
| Forest Investigative Site 018 | Greensboro | North Carolina | 27408 | — |
| Forest Investigative Site 002 | Greenville | North Carolina | 27834 | — |
| Forest Investigative Site 024 | Salisbury | North Carolina | 28144 | — |
| Forest Investigative Site 042 | Winston-Salem | North Carolina | 27103 | — |
| Forest Investigative Site 003 | Cincinnati | Ohio | 45219 | — |
| Forest Investigative Site 005 | Cleveland | Ohio | 44122 | — |
| Forest Investigative Site 059 | Columbus | Ohio | 43212 | — |
| Forest Investigative Site 044 | Eugene | Oregon | 97401 | — |
| Forest Investigative Site 010 | Eugene | Oregon | 97404 | — |
| Forest Investigative Site 001 | Medford | Oregon | 97504 | — |
| Forest Investigative Site 052 | Medford | Oregon | 97504 | — |
| Forest Investigative Site 041 | Portland | Oregon | 97205 | — |
| Forest Investigative Site 051 | Duncansville | Pennsylvania | 16635 | — |
| Forest Investigative Site 046 | Mechanicsburg | Pennsylvania | 17055 | — |
| Forest Investigative Site 028 | Anderson | South Carolina | 29621 | — |
| Forest Investigative Site 021 | Greer | South Carolina | 29651 | — |
| Forest Investigative Site 006 | Salt Lake City | Utah | 84102 | — |
| Forest Investigative Site 015 | Chesapeake | Virginia | 23320 | — |
| Forest Investigative Site 047 | Seattle | Washington | 98104 | — |
| Forest Investigative Site 036 | Wenatchee | Washington | 98801 | — |
| Forest Investigative Site 063 | Racine | Wisconsin | 53406 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01014585, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 7, 2011 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01014585 live on ClinicalTrials.gov.